Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for regression of left ventricular hypertrophy in type 2 diabetes
ISRCTN96755104Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Feb 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in left ventricular hypertrophy (LVH) comparing Allopurinol with Placebo (2 arms). Primary endpoint: Reduction in left ventricular hypertrophy. Started Feb 2009; status: completed.
02
Drugs
allopurinol
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on ISRCTN96755104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96755104.